BACKGROUND: Multiple modalities have been used in the treatment of melasma, such as bleaching agents, chemical peels, and antioxidants. Topical zinc sulfate has peeling and antioxidant effects. OBJECTIVE: The objective was to evaluate the efficacy and safety of topical 10% zinc sulfate solution in the treatment of melasma. PATIENTS & METHODS: This study was conducted at the Department of Dermatology & Venereology, Baghdad Teaching Hospital. Twenty-eight patients with melasma were treated with 10% zinc sulfate solution. Every patient was instructed to apply the formula twice daily and to be seen every 2 weeks for 2 months. The severity of melasma was assessed before, during, and after treatment with the melasma area and severity index (MASI). All patients were instructed to apply a broad-spectrum sunscreen with SPF>30 before sun exposure during treatment and for the 3-month follow-up period. RESULTS: Fourteen patients were treated with 10% zinc sulfate solution. The mean MASI score before treatment was 9.45, which changed to 4.70 after therapy. This corresponds to a percentage improvement of 49.78% and was statistically significant (p<.0005). No side effects were reported apart from a mild stinging sensation reported in a few patients. Most patients maintained improvement 3 months after cessation of therapy. CONCLUSION: Topical 10% zinc sulfate solution is a new effective, safe, and noncostly formulation in the treatment of melasma.
BACKGROUND: Multiple modalities have been used in the treatment of melasma, such as bleaching agents, chemical peels, and antioxidants. Topical zinc sulfate has peeling and antioxidant effects. OBJECTIVE: The objective was to evaluate the efficacy and safety of topical 10% zinc sulfate solution in the treatment of melasma. PATIENTS & METHODS: This study was conducted at the Department of Dermatology & Venereology, Baghdad Teaching Hospital. Twenty-eight patients with melasma were treated with 10% zinc sulfate solution. Every patient was instructed to apply the formula twice daily and to be seen every 2 weeks for 2 months. The severity of melasma was assessed before, during, and after treatment with the melasma area and severity index (MASI). All patients were instructed to apply a broad-spectrum sunscreen with SPF>30 before sun exposure during treatment and for the 3-month follow-up period. RESULTS: Fourteen patients were treated with 10% zinc sulfate solution. The mean MASI score before treatment was 9.45, which changed to 4.70 after therapy. This corresponds to a percentage improvement of 49.78% and was statistically significant (p<.0005). No side effects were reported apart from a mild stinging sensation reported in a few patients. Most patients maintained improvement 3 months after cessation of therapy. CONCLUSION: Topical 10% zinc sulfate solution is a new effective, safe, and noncostly formulation in the treatment of melasma.
Authors: Amal Alrashidi; Mohammed Jafar; Niamh Higgins; Ciara Mulligan; Carmine Varricchio; Ryan Moseley; Vildan Celiksoy; David M J Houston; Charles M Heard Journal: Biomolecules Date: 2021-12-16